esmolol has been researched along with natriuretic peptide, brain in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burnett, JC; Redfield, MM; Yamamoto, K | 1 |
Cao, W; He, YF; Li, PJ; Li, X; Li, ZL; Yang, L; Zeng, H; Zhang, ZY | 1 |
Boldt, J; Mengistu, AM; Piper, SN; Röhm, KD; Suttner, SW; Wolf, MW | 1 |
Christou, A; Fournarakis, GM; Koutouzis, MJ; Maisel, AS; Nikolaou, NI; Patsilinakos, SP; Rompola, A | 1 |
Biesenbach, E; Caglayan, E; Dahlem, KM; Er, F; Eran-Ergöknil, A; Erdmann, E; Gassanov, N; Hellmich, M; Herrfurth, T; Kuhr, K; Le, MT; Nia, AM; Taghiyev, Z; Vanezi, M; Waltenberger, J; Yüksel, D | 1 |
Fang, DH; Gao, K; Hu, BL; Qi, BX; Qi, GJ; Zhu, L | 1 |
3 trial(s) available for esmolol and natriuretic peptide, brain
Article | Year |
---|---|
Influence of controlled hypotension using esmolol and sodium nitroprusside on natriuretic peptides in patients undergoing endonasal sinus surgery.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atrial Natriuretic Factor; Elective Surgical Procedures; Female; Humans; Hypotension, Controlled; Male; Middle Aged; Monitoring, Physiologic; Natriuretic Peptide, Brain; Nitroprusside; Paranasal Sinuses; Propanolamines; Vasodilator Agents | 2007 |
Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Biomarkers; Creatine Kinase; Female; Germany; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Percutaneous Coronary Intervention; Prognosis; Propanolamines; Prospective Studies; Shock, Cardiogenic; Single-Blind Method; Tachycardia, Ventricular; Troponin T | 2016 |
[Application of esmolol in severe hand, foot, and mouth disease].
Topics: Adrenergic beta-1 Receptor Antagonists; Child, Preschool; Female; Hand, Foot and Mouth Disease; Humans; Infant; Interleukin-6; Male; Natriuretic Peptide, Brain; Peptide Fragments; Propanolamines; Prospective Studies; Tumor Necrosis Factor-alpha | 2017 |
3 other study(ies) available for esmolol and natriuretic peptide, brain
Article | Year |
---|---|
Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Cardiomyopathies; Coronary Circulation; Coronary Vessels; Cyclic GMP; Dogs; Heart Failure; Heart Rate; Hemodynamics; Humans; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Polysaccharides; Propanolamines; Receptors, Atrial Natriuretic Factor; Tachycardia; Vascular Resistance; Ventricular Function, Left | 1997 |
Effects of short-acting beta-adrenergic blocker on B-type natriuretic peptide at early stage of postresuscitation in rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; Diastole; Female; Male; Natriuretic Peptide, Brain; Propanolamines; Rabbits; Ventricular Function, Left | 2006 |
B-type natriuretic peptide blood levels identify patients with non-ST elevation acute coronary syndromes at high risk for complications during intravenous beta-blocker infusion.
Topics: Acute Coronary Syndrome; Adrenergic beta-1 Receptor Antagonists; Arrhythmias, Cardiac; Biomarkers; Blood Pressure; Drug Administration Schedule; Echocardiography; Female; Greece; Humans; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Predictive Value of Tests; Propanolamines; Retrospective Studies | 2011 |